Quest Diagnostics promotes Stephen H. Rusckowski to chairman
Prior to joining Quest Diagnostics in 2012, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics.
Mr. Rusckowski joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.
Mr. Rusckowski is a member of the Board of Directors of Xerox and Project Hope. He is also currently the Chairman of the American Clinical Laboratory Association.
Mr. Rusckowski earned a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute and a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management.
The company's independent directors also designated Daniel C. Stanzione, Ph.D. as Lead Independent Director from January 1, 2017.
Dr. Stanzione retired from Lucent Technologies Incorporated in 2000 and is President Emeritus of Bell Laboratories and an independent consultant.
Dr. Stanzione began his career in 1972 with Bell Laboratories, where he led the teams working on the first microprocessors and digital signal processors.
He was appointed President of Network Systems, Lucent’s largest business unit, in 1996 and was appointed Chief Operating Officer of Lucent in 1997.
Dr. Stanzione is a director of InterNAP Corporation, where he serves as non-executive chairman. He served as a director of Avaya Inc. from 2000 until 2007.
He has been a director of Quest Diagnostics since January 1997 and served as Non-Executive Chairman of the Board from May, 2012 to December, 2016.